SCHEMBL26430802

SCHEMBL26430802

c1ccc(-c2ccc(N(c3ccc4c(c3)oc3ccccc34)c3ccc4c(c3)oc3c4ccc4c3c3ccccc3n4-c3ccccc3)cc2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.35
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
HSD17B10 Q99714 2/20 0.35
POLB P06746 1/20 0.35
TSHR P16473 1/20 0.35
BRCA1 P38398 1/20 0.35
KDM4E B2RXH2 3/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
ATM Q13315 1/20 0.35
PPARG P37231 1/20 0.32
RXFP1 Q9HBX9 1/20 0.32
NR2E3 Q9Y5X4 1/20 0.32
NCOR2 Q9Y618 1/20 0.32
AHR P35869 1/20 0.32
MAPT P10636 2/20 0.31
HPGD P15428 2/20 0.31
CYP3A4 P08684 1/20 0.31
ALPI P09923 1/20 0.31
GAA P10253 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26430797 0.97 L3MBTL1 (0.37) ALDH1A1MEN1KMT2AHSD17B10POLB
SCHEMBL26430787 0.97 L3MBTL1 (0.37) ALDH1A1MEN1KMT2AHSD17B10POLB
SCHEMBL26430764 0.95 ALDH1A1 (0.34) ALDH1A1MEN1KMT2AHSD17B10POLB
SCHEMBL26430796 0.94 MEN1 (0.35) ALDH1A1MEN1KMT2AHSD17B10POLB
SCHEMBL31771 0.93 KDM4E (0.37) ALDH1A1MEN1KMT2AHSD17B10POLB
SCHEMBL26430791 0.93 MEN1 (0.34) ALDH1A1MEN1KMT2AHSD17B10POLB
SCHEMBL10108652 0.93 ALDH1A1 (0.34) ALDH1A1MEN1KMT2AHSD17B10POLB
SCHEMBL26430808 0.93 L3MBTL1 (0.37) ALDH1A1MEN1KMT2AHSD17B10POLB
SCHEMBL17126096 0.92 KDM4E (0.36) ALDH1A1MEN1KMT2AHSD17B10POLB
SCHEMBL17126100 0.92 KDM4E (0.36) ALDH1A1MEN1KMT2AHSD17B10POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230130126-A1 HETERO-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME LT MATERIALS CO., LTD. (KR) 2023-04-27 US disclosed
US-20230130126-A1 HETERO-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME LT MATERIALS CO., LTD. (KR) 2023-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230130126-A1 HETERO-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME CRY1, PER2, CRY2 ALDH1A1 1355/4885MEN1 3166/4885KMT2A 1244/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.